Group	B:C0026845
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
limit	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
exercise	O
in	O
humans	O
.	O

Group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	B:C0027883
limit	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
exercise	O
in	O
humans	O
.	O

Group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
limit	O
the	O
intramuscular	B:C0442117
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
exercise	O
in	O
humans	O
.	O

Group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
limit	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	B:C0444584
body	I:C0444584
exercise	O
in	O
humans	O
.	O

Group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
limit	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
exercise	O
in	O
humans	B:C0086418
.	O

The	O
purpose	O
of	O
this	O
study	B:C2603343
was	O
to	O
determine	O
the	O
role	O
of	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
endurance	O
exercise	O
-	O
induced	O
metabolic	O
perturbation	O
assayed	O
in	O
muscle	O
biopsy	O
samples	I:C0677862
taken	O
from	O
locomotor	O
muscle	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	B:C1148554
the	O
role	O
of	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
endurance	O
exercise	O
-	O
induced	O
metabolic	O
perturbation	O
assayed	O
in	O
muscle	O
biopsy	O
samples	I:C0677862
taken	O
from	O
locomotor	O
muscle	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
role	O
of	O
group	B:C0026845
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
endurance	O
exercise	O
-	O
induced	O
metabolic	O
perturbation	O
assayed	O
in	O
muscle	O
biopsy	O
samples	I:C0677862
taken	O
from	O
locomotor	O
muscle	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
role	O
of	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	B:C0027883
in	O
limiting	O
the	O
endurance	O
exercise	O
-	O
induced	O
metabolic	O
perturbation	O
assayed	O
in	O
muscle	O
biopsy	O
samples	I:C0677862
taken	O
from	O
locomotor	O
muscle	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
role	O
of	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
endurance	B:C0518031
exercise	O
-	O
induced	O
metabolic	O
perturbation	O
assayed	O
in	O
muscle	O
biopsy	O
samples	I:C0677862
taken	O
from	O
locomotor	O
muscle	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
role	O
of	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
endurance	O
exercise	O
-	O
induced	O
metabolic	O
perturbation	O
assayed	B:C1510438
in	O
muscle	O
biopsy	O
samples	I:C0677862
taken	O
from	O
locomotor	O
muscle	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
role	O
of	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
endurance	O
exercise	O
-	O
induced	O
metabolic	O
perturbation	O
assayed	O
in	O
muscle	B:C0026845
biopsy	O
samples	I:C0677862
taken	O
from	O
locomotor	O
muscle	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
role	O
of	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
endurance	O
exercise	O
-	O
induced	O
metabolic	O
perturbation	O
assayed	O
in	O
muscle	O
biopsy	B:C0677862
samples	I:C0677862
taken	O
from	O
locomotor	O
muscle	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
role	O
of	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
endurance	O
exercise	O
-	O
induced	O
metabolic	O
perturbation	O
assayed	O
in	O
muscle	O
biopsy	O
samples	I:C0677862
taken	O
from	O
locomotor	B:C0023946
muscle	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
role	O
of	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
endurance	O
exercise	O
-	O
induced	O
metabolic	O
perturbation	O
assayed	O
in	O
muscle	O
biopsy	O
samples	I:C0677862
taken	O
from	O
locomotor	O
muscle	B:C0026845
.	O

Lumbar	B:C0024090
intrathecal	O
fentanyl	O
was	O
used	O
to	O
attenuate	O
the	O
central	O
projection	O
of	O
μ	O
-	I:C0066908
opioid	I:C0066908
receptor	I:C0066908
-	O
sensitive	O
locomotor	O
muscle	O
afferents	O
during	O
a	O
5	O
km	O
cycling	O
time	O
trial	O
.	O

Lumbar	O
intrathecal	B:C1370196
fentanyl	O
was	O
used	O
to	O
attenuate	O
the	O
central	O
projection	O
of	O
μ	O
-	I:C0066908
opioid	I:C0066908
receptor	I:C0066908
-	O
sensitive	O
locomotor	O
muscle	O
afferents	O
during	O
a	O
5	O
km	O
cycling	O
time	O
trial	O
.	O

Lumbar	O
intrathecal	O
fentanyl	B:C0015846
was	O
used	O
to	O
attenuate	O
the	O
central	O
projection	O
of	O
μ	O
-	I:C0066908
opioid	I:C0066908
receptor	I:C0066908
-	O
sensitive	O
locomotor	O
muscle	O
afferents	O
during	O
a	O
5	O
km	O
cycling	O
time	O
trial	O
.	O

Lumbar	O
intrathecal	O
fentanyl	O
was	O
used	O
to	O
attenuate	O
the	O
central	B:C0205099
projection	O
of	O
μ	O
-	I:C0066908
opioid	I:C0066908
receptor	I:C0066908
-	O
sensitive	O
locomotor	O
muscle	O
afferents	O
during	O
a	O
5	O
km	O
cycling	O
time	O
trial	O
.	O

Lumbar	O
intrathecal	O
fentanyl	O
was	O
used	O
to	O
attenuate	O
the	O
central	O
projection	B:C0348018
of	O
μ	O
-	I:C0066908
opioid	I:C0066908
receptor	I:C0066908
-	O
sensitive	O
locomotor	O
muscle	O
afferents	O
during	O
a	O
5	O
km	O
cycling	O
time	O
trial	O
.	O

Lumbar	O
intrathecal	O
fentanyl	O
was	O
used	O
to	O
attenuate	O
the	O
central	O
projection	O
of	O
μ	B:C0066908
-	I:C0066908
opioid	I:C0066908
receptor	I:C0066908
-	O
sensitive	O
locomotor	O
muscle	O
afferents	O
during	O
a	O
5	O
km	O
cycling	O
time	O
trial	O
.	O

Lumbar	O
intrathecal	O
fentanyl	O
was	O
used	O
to	O
attenuate	O
the	O
central	O
projection	O
of	O
μ	O
-	I:C0066908
opioid	I:C0066908
receptor	I:C0066908
-	O
sensitive	O
locomotor	B:C0023946
muscle	O
afferents	O
during	O
a	O
5	O
km	O
cycling	O
time	O
trial	O
.	O

Lumbar	O
intrathecal	O
fentanyl	O
was	O
used	O
to	O
attenuate	O
the	O
central	O
projection	O
of	O
μ	O
-	I:C0066908
opioid	I:C0066908
receptor	I:C0066908
-	O
sensitive	O
locomotor	O
muscle	B:C0026845
afferents	O
during	O
a	O
5	O
km	O
cycling	O
time	O
trial	O
.	O

Lumbar	O
intrathecal	O
fentanyl	O
was	O
used	O
to	O
attenuate	O
the	O
central	O
projection	O
of	O
μ	O
-	I:C0066908
opioid	I:C0066908
receptor	I:C0066908
-	O
sensitive	O
locomotor	O
muscle	O
afferents	B:C0027883
during	O
a	O
5	O
km	O
cycling	O
time	O
trial	O
.	O

Lumbar	O
intrathecal	O
fentanyl	O
was	O
used	O
to	O
attenuate	O
the	O
central	O
projection	O
of	O
μ	O
-	I:C0066908
opioid	I:C0066908
receptor	I:C0066908
-	O
sensitive	O
locomotor	O
muscle	O
afferents	O
during	O
a	O
5	O
km	O
cycling	O
time	O
trial	B:C0008976
.	O

The	O
findings	B:C0243095
suggest	O
that	O
the	O
central	O
projection	O
of	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferent	O
feedback	O
constrains	O
voluntary	O
neural	O
'	O
drive	O
'	O
to	O
working	O
locomotor	O
muscle	O
and	O
limits	O
the	O
exercise	O
-	O
induced	O
intramuscular	O
metabolic	O
perturbation	O
.	O

The	O
findings	O
suggest	O
that	O
the	O
central	B:C0205099
projection	O
of	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferent	O
feedback	O
constrains	O
voluntary	O
neural	O
'	O
drive	O
'	O
to	O
working	O
locomotor	O
muscle	O
and	O
limits	O
the	O
exercise	O
-	O
induced	O
intramuscular	O
metabolic	O
perturbation	O
.	O

The	O
findings	O
suggest	O
that	O
the	O
central	O
projection	B:C0348018
of	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferent	O
feedback	O
constrains	O
voluntary	O
neural	O
'	O
drive	O
'	O
to	O
working	O
locomotor	O
muscle	O
and	O
limits	O
the	O
exercise	O
-	O
induced	O
intramuscular	O
metabolic	O
perturbation	O
.	O

The	O
findings	O
suggest	O
that	O
the	O
central	O
projection	O
of	O
group	B:C0026845
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferent	O
feedback	O
constrains	O
voluntary	O
neural	O
'	O
drive	O
'	O
to	O
working	O
locomotor	O
muscle	O
and	O
limits	O
the	O
exercise	O
-	O
induced	O
intramuscular	O
metabolic	O
perturbation	O
.	O

The	O
findings	O
suggest	O
that	O
the	O
central	O
projection	O
of	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferent	B:C0027883
feedback	O
constrains	O
voluntary	O
neural	O
'	O
drive	O
'	O
to	O
working	O
locomotor	O
muscle	O
and	O
limits	O
the	O
exercise	O
-	O
induced	O
intramuscular	O
metabolic	O
perturbation	O
.	O

The	O
findings	O
suggest	O
that	O
the	O
central	O
projection	O
of	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferent	O
feedback	B:C0678663
constrains	O
voluntary	O
neural	O
'	O
drive	O
'	O
to	O
working	O
locomotor	O
muscle	O
and	O
limits	O
the	O
exercise	O
-	O
induced	O
intramuscular	O
metabolic	O
perturbation	O
.	O

The	O
findings	O
suggest	O
that	O
the	O
central	O
projection	O
of	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferent	O
feedback	O
constrains	O
voluntary	O
neural	O
'	O
drive	B:C0013126
'	O
to	O
working	O
locomotor	O
muscle	O
and	O
limits	O
the	O
exercise	O
-	O
induced	O
intramuscular	O
metabolic	O
perturbation	O
.	O

The	O
findings	O
suggest	O
that	O
the	O
central	O
projection	O
of	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferent	O
feedback	O
constrains	O
voluntary	O
neural	O
'	O
drive	O
'	O
to	O
working	O
locomotor	B:C0023946
muscle	O
and	O
limits	O
the	O
exercise	O
-	O
induced	O
intramuscular	O
metabolic	O
perturbation	O
.	O

The	O
findings	O
suggest	O
that	O
the	O
central	O
projection	O
of	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferent	O
feedback	O
constrains	O
voluntary	O
neural	O
'	O
drive	O
'	O
to	O
working	O
locomotor	O
muscle	B:C0026845
and	O
limits	O
the	O
exercise	O
-	O
induced	O
intramuscular	O
metabolic	O
perturbation	O
.	O

The	O
findings	O
suggest	O
that	O
the	O
central	O
projection	O
of	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferent	O
feedback	O
constrains	O
voluntary	O
neural	O
'	O
drive	O
'	O
to	O
working	O
locomotor	O
muscle	O
and	O
limits	O
the	O
exercise	O
-	O
induced	O
intramuscular	B:C0442117
metabolic	O
perturbation	O
.	O

Therefore	O
,	O
the	O
CNS	B:C3714787
might	O
regulate	O
the	O
degree	O
of	O
metabolic	O
perturbation	O
within	O
locomotor	O
muscle	O
and	O
thereby	O
limit	O
peripheral	O
fatigue	O
.	O

Therefore	O
,	O
the	O
CNS	O
might	O
regulate	B:C1327622
the	O
degree	O
of	O
metabolic	O
perturbation	O
within	O
locomotor	O
muscle	O
and	O
thereby	O
limit	O
peripheral	O
fatigue	O
.	O

Therefore	O
,	O
the	O
CNS	O
might	O
regulate	O
the	O
degree	O
of	O
metabolic	O
perturbation	O
within	O
locomotor	B:C0023946
muscle	O
and	O
thereby	O
limit	O
peripheral	O
fatigue	O
.	O

Therefore	O
,	O
the	O
CNS	O
might	O
regulate	O
the	O
degree	O
of	O
metabolic	O
perturbation	O
within	O
locomotor	O
muscle	B:C0026845
and	O
thereby	O
limit	O
peripheral	O
fatigue	O
.	O

Therefore	O
,	O
the	O
CNS	O
might	O
regulate	O
the	O
degree	O
of	O
metabolic	O
perturbation	O
within	O
locomotor	O
muscle	O
and	O
thereby	O
limit	O
peripheral	B:C0205100
fatigue	O
.	O

Therefore	O
,	O
the	O
CNS	O
might	O
regulate	O
the	O
degree	O
of	O
metabolic	O
perturbation	O
within	O
locomotor	O
muscle	O
and	O
thereby	O
limit	O
peripheral	O
fatigue	B:C0015672
.	O

It	O
appears	O
that	O
the	O
group	B:C0026845
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
are	O
an	O
important	O
neural	O
link	O
in	O
this	O
regulatory	O
mechanism	O
,	O
which	O
probably	O
serves	O
to	O
protect	O
locomotor	O
muscle	O
from	O
the	O
potentially	O
severe	O
functional	O
impairment	O
as	O
a	O
consequence	O
of	O
severe	O
intramuscular	O
metabolic	O
disturbance	O
.	O

It	O
appears	O
that	O
the	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	B:C0027883
are	O
an	O
important	O
neural	O
link	O
in	O
this	O
regulatory	O
mechanism	O
,	O
which	O
probably	O
serves	O
to	O
protect	O
locomotor	O
muscle	O
from	O
the	O
potentially	O
severe	O
functional	O
impairment	O
as	O
a	O
consequence	O
of	O
severe	O
intramuscular	O
metabolic	O
disturbance	O
.	O

It	O
appears	O
that	O
the	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
are	O
an	O
important	O
neural	O
link	O
in	O
this	O
regulatory	B:C1327622
mechanism	O
,	O
which	O
probably	O
serves	O
to	O
protect	O
locomotor	O
muscle	O
from	O
the	O
potentially	O
severe	O
functional	O
impairment	O
as	O
a	O
consequence	O
of	O
severe	O
intramuscular	O
metabolic	O
disturbance	O
.	O

It	O
appears	O
that	O
the	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
are	O
an	O
important	O
neural	O
link	O
in	O
this	O
regulatory	O
mechanism	O
,	O
which	O
probably	O
serves	O
to	O
protect	O
locomotor	B:C0023946
muscle	O
from	O
the	O
potentially	O
severe	O
functional	O
impairment	O
as	O
a	O
consequence	O
of	O
severe	O
intramuscular	O
metabolic	O
disturbance	O
.	O

It	O
appears	O
that	O
the	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
are	O
an	O
important	O
neural	O
link	O
in	O
this	O
regulatory	O
mechanism	O
,	O
which	O
probably	O
serves	O
to	O
protect	O
locomotor	O
muscle	B:C0026845
from	O
the	O
potentially	O
severe	O
functional	O
impairment	O
as	O
a	O
consequence	O
of	O
severe	O
intramuscular	O
metabolic	O
disturbance	O
.	O

It	O
appears	O
that	O
the	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
are	O
an	O
important	O
neural	O
link	O
in	O
this	O
regulatory	O
mechanism	O
,	O
which	O
probably	O
serves	O
to	O
protect	O
locomotor	O
muscle	O
from	O
the	O
potentially	O
severe	O
functional	O
impairment	O
as	O
a	O
consequence	O
of	O
severe	O
intramuscular	B:C0442117
metabolic	O
disturbance	O
.	O

To	O
investigate	O
the	O
role	O
of	O
metabo	B:C0025519
-	O
and	O
mechanosensitive	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
endurance	O
exercise	O
,	O
eight	O
subjects	O
performed	O
5	O
km	O
cycling	O
time	O
trials	O
under	O
control	I:C2911690
conditions	I:C2911690
(	O
control	O
conditions	I:C2911690
)	O
and	O
with	O
lumbar	O
intrathecal	O
fentanyl	O
impairing	O
lower	O
limb	I:C0023216
muscle	O
afferent	O
feedback	O
(	O
FENT	O
)	O
.	O

To	O
investigate	O
the	O
role	O
of	O
metabo	O
-	O
and	O
mechanosensitive	O
group	B:C0026845
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
endurance	O
exercise	O
,	O
eight	O
subjects	O
performed	O
5	O
km	O
cycling	O
time	O
trials	O
under	O
control	I:C2911690
conditions	I:C2911690
(	O
control	O
conditions	I:C2911690
)	O
and	O
with	O
lumbar	O
intrathecal	O
fentanyl	O
impairing	O
lower	O
limb	I:C0023216
muscle	O
afferent	O
feedback	O
(	O
FENT	O
)	O
.	O

To	O
investigate	O
the	O
role	O
of	O
metabo	O
-	O
and	O
mechanosensitive	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	B:C0027883
in	O
limiting	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
endurance	O
exercise	O
,	O
eight	O
subjects	O
performed	O
5	O
km	O
cycling	O
time	O
trials	O
under	O
control	I:C2911690
conditions	I:C2911690
(	O
control	O
conditions	I:C2911690
)	O
and	O
with	O
lumbar	O
intrathecal	O
fentanyl	O
impairing	O
lower	O
limb	I:C0023216
muscle	O
afferent	O
feedback	O
(	O
FENT	O
)	O
.	O

To	O
investigate	O
the	O
role	O
of	O
metabo	O
-	O
and	O
mechanosensitive	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
intramuscular	B:C0442117
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
endurance	O
exercise	O
,	O
eight	O
subjects	O
performed	O
5	O
km	O
cycling	O
time	O
trials	O
under	O
control	I:C2911690
conditions	I:C2911690
(	O
control	O
conditions	I:C2911690
)	O
and	O
with	O
lumbar	O
intrathecal	O
fentanyl	O
impairing	O
lower	O
limb	I:C0023216
muscle	O
afferent	O
feedback	O
(	O
FENT	O
)	O
.	O

To	O
investigate	O
the	O
role	O
of	O
metabo	O
-	O
and	O
mechanosensitive	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	B:C0444584
body	I:C0444584
endurance	O
exercise	O
,	O
eight	O
subjects	O
performed	O
5	O
km	O
cycling	O
time	O
trials	O
under	O
control	I:C2911690
conditions	I:C2911690
(	O
control	O
conditions	I:C2911690
)	O
and	O
with	O
lumbar	O
intrathecal	O
fentanyl	O
impairing	O
lower	O
limb	I:C0023216
muscle	O
afferent	O
feedback	O
(	O
FENT	O
)	O
.	O

To	O
investigate	O
the	O
role	O
of	O
metabo	O
-	O
and	O
mechanosensitive	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
endurance	B:C0518031
exercise	O
,	O
eight	O
subjects	O
performed	O
5	O
km	O
cycling	O
time	O
trials	O
under	O
control	I:C2911690
conditions	I:C2911690
(	O
control	O
conditions	I:C2911690
)	O
and	O
with	O
lumbar	O
intrathecal	O
fentanyl	O
impairing	O
lower	O
limb	I:C0023216
muscle	O
afferent	O
feedback	O
(	O
FENT	O
)	O
.	O

To	O
investigate	O
the	O
role	O
of	O
metabo	O
-	O
and	O
mechanosensitive	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
endurance	O
exercise	O
,	O
eight	O
subjects	O
performed	O
5	O
km	O
cycling	O
time	O
trials	B:C0008976
under	O
control	I:C2911690
conditions	I:C2911690
(	O
control	O
conditions	I:C2911690
)	O
and	O
with	O
lumbar	O
intrathecal	O
fentanyl	O
impairing	O
lower	O
limb	I:C0023216
muscle	O
afferent	O
feedback	O
(	O
FENT	O
)	O
.	O

To	O
investigate	O
the	O
role	O
of	O
metabo	O
-	O
and	O
mechanosensitive	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
endurance	O
exercise	O
,	O
eight	O
subjects	O
performed	O
5	O
km	O
cycling	O
time	O
trials	O
under	B:C2911690
control	I:C2911690
conditions	I:C2911690
(	O
control	O
conditions	I:C2911690
)	O
and	O
with	O
lumbar	O
intrathecal	O
fentanyl	O
impairing	O
lower	O
limb	I:C0023216
muscle	O
afferent	O
feedback	O
(	O
FENT	O
)	O
.	O

To	O
investigate	O
the	O
role	O
of	O
metabo	O
-	O
and	O
mechanosensitive	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
endurance	O
exercise	O
,	O
eight	O
subjects	O
performed	O
5	O
km	O
cycling	O
time	O
trials	O
under	O
control	I:C2911690
conditions	I:C2911690
(	O
control	B:C2911690
conditions	I:C2911690
)	O
and	O
with	O
lumbar	O
intrathecal	O
fentanyl	O
impairing	O
lower	O
limb	I:C0023216
muscle	O
afferent	O
feedback	O
(	O
FENT	O
)	O
.	O

To	O
investigate	O
the	O
role	O
of	O
metabo	O
-	O
and	O
mechanosensitive	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
endurance	O
exercise	O
,	O
eight	O
subjects	O
performed	O
5	O
km	O
cycling	O
time	O
trials	O
under	O
control	I:C2911690
conditions	I:C2911690
(	O
control	O
conditions	I:C2911690
)	O
and	O
with	O
lumbar	B:C0024090
intrathecal	O
fentanyl	O
impairing	O
lower	O
limb	I:C0023216
muscle	O
afferent	O
feedback	O
(	O
FENT	O
)	O
.	O

To	O
investigate	O
the	O
role	O
of	O
metabo	O
-	O
and	O
mechanosensitive	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
endurance	O
exercise	O
,	O
eight	O
subjects	O
performed	O
5	O
km	O
cycling	O
time	O
trials	O
under	O
control	I:C2911690
conditions	I:C2911690
(	O
control	O
conditions	I:C2911690
)	O
and	O
with	O
lumbar	O
intrathecal	B:C1370196
fentanyl	O
impairing	O
lower	O
limb	I:C0023216
muscle	O
afferent	O
feedback	O
(	O
FENT	O
)	O
.	O

To	O
investigate	O
the	O
role	O
of	O
metabo	O
-	O
and	O
mechanosensitive	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
endurance	O
exercise	O
,	O
eight	O
subjects	O
performed	O
5	O
km	O
cycling	O
time	O
trials	O
under	O
control	I:C2911690
conditions	I:C2911690
(	O
control	O
conditions	I:C2911690
)	O
and	O
with	O
lumbar	O
intrathecal	O
fentanyl	B:C0015846
impairing	O
lower	O
limb	I:C0023216
muscle	O
afferent	O
feedback	O
(	O
FENT	O
)	O
.	O

To	O
investigate	O
the	O
role	O
of	O
metabo	O
-	O
and	O
mechanosensitive	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
endurance	O
exercise	O
,	O
eight	O
subjects	O
performed	O
5	O
km	O
cycling	O
time	O
trials	O
under	O
control	I:C2911690
conditions	I:C2911690
(	O
control	O
conditions	I:C2911690
)	O
and	O
with	O
lumbar	O
intrathecal	O
fentanyl	O
impairing	O
lower	B:C0023216
limb	I:C0023216
muscle	O
afferent	O
feedback	O
(	O
FENT	O
)	O
.	O

To	O
investigate	O
the	O
role	O
of	O
metabo	O
-	O
and	O
mechanosensitive	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
endurance	O
exercise	O
,	O
eight	O
subjects	O
performed	O
5	O
km	O
cycling	O
time	O
trials	O
under	O
control	I:C2911690
conditions	I:C2911690
(	O
control	O
conditions	I:C2911690
)	O
and	O
with	O
lumbar	O
intrathecal	O
fentanyl	O
impairing	O
lower	O
limb	I:C0023216
muscle	B:C0026845
afferent	O
feedback	O
(	O
FENT	O
)	O
.	O

To	O
investigate	O
the	O
role	O
of	O
metabo	O
-	O
and	O
mechanosensitive	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
endurance	O
exercise	O
,	O
eight	O
subjects	O
performed	O
5	O
km	O
cycling	O
time	O
trials	O
under	O
control	I:C2911690
conditions	I:C2911690
(	O
control	O
conditions	I:C2911690
)	O
and	O
with	O
lumbar	O
intrathecal	O
fentanyl	O
impairing	O
lower	O
limb	I:C0023216
muscle	O
afferent	B:C0027883
feedback	O
(	O
FENT	O
)	O
.	O

To	O
investigate	O
the	O
role	O
of	O
metabo	O
-	O
and	O
mechanosensitive	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
endurance	O
exercise	O
,	O
eight	O
subjects	O
performed	O
5	O
km	O
cycling	O
time	O
trials	O
under	O
control	I:C2911690
conditions	I:C2911690
(	O
control	O
conditions	I:C2911690
)	O
and	O
with	O
lumbar	O
intrathecal	O
fentanyl	O
impairing	O
lower	O
limb	I:C0023216
muscle	O
afferent	O
feedback	B:C0678663
(	O
FENT	O
)	O
.	O

To	O
investigate	O
the	O
role	O
of	O
metabo	O
-	O
and	O
mechanosensitive	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
in	O
limiting	O
the	O
intramuscular	O
metabolic	O
perturbation	O
during	O
whole	O
body	I:C0444584
endurance	O
exercise	O
,	O
eight	O
subjects	O
performed	O
5	O
km	O
cycling	O
time	O
trials	O
under	O
control	I:C2911690
conditions	I:C2911690
(	O
control	O
conditions	I:C2911690
)	O
and	O
with	O
lumbar	O
intrathecal	O
fentanyl	O
impairing	O
lower	O
limb	I:C0023216
muscle	O
afferent	O
feedback	O
(	O
FENT	B:C0678663
)	O
.	O

Vastus	B:C0224444
lateralis	I:C0224444
muscle	O
biopsies	O
were	O
obtained	O
before	O
and	O
immediately	O
after	O
exercise	O
.	O

Vastus	O
lateralis	I:C0224444
muscle	B:C0026845
biopsies	O
were	O
obtained	O
before	O
and	O
immediately	O
after	O
exercise	O
.	O

Vastus	O
lateralis	I:C0224444
muscle	O
biopsies	B:C0677862
were	O
obtained	O
before	O
and	O
immediately	O
after	O
exercise	O
.	O

Motoneuronal	B:C0026609
output	O
was	I:C0204709
estimated	I:C0204709
through	O
vastus	O
lateralis	I:C0224444
surface	I:C0224444
electromyography	O
(	O
electromyography	O
)	O
.	O

Motoneuronal	O
output	B:C0204709
was	I:C0204709
estimated	I:C0204709
through	O
vastus	O
lateralis	I:C0224444
surface	I:C0224444
electromyography	O
(	O
electromyography	O
)	O
.	O

Motoneuronal	O
output	O
was	I:C0204709
estimated	I:C0204709
through	O
vastus	B:C0224444
lateralis	I:C0224444
surface	I:C0224444
electromyography	O
(	O
electromyography	O
)	O
.	O

Motoneuronal	O
output	O
was	I:C0204709
estimated	I:C0204709
through	O
vastus	O
lateralis	I:C0224444
surface	I:C0224444
electromyography	B:C0013839
(	O
electromyography	O
)	O
.	O

Motoneuronal	O
output	O
was	I:C0204709
estimated	I:C0204709
through	O
vastus	O
lateralis	I:C0224444
surface	I:C0224444
electromyography	O
(	O
electromyography	B:C0013839
)	O
.	O

Exercise	O
-	O
induced	O
changes	O
in	O
intramuscular	B:C0442117
metabolites	O
were	O
determine	O
d	O
using	O
liquid	O
and	O
gas	O
chromatography	I:C1720784
-	I:C1720784
mass	I:C1720784
spectrometry	I:C1720784
.	O

Exercise	O
-	O
induced	O
changes	O
in	O
intramuscular	O
metabolites	B:C0870883
were	O
determine	O
d	O
using	O
liquid	O
and	O
gas	O
chromatography	I:C1720784
-	I:C1720784
mass	I:C1720784
spectrometry	I:C1720784
.	O

Exercise	O
-	O
induced	O
changes	O
in	O
intramuscular	O
metabolites	O
were	O
determine	B:C1148554
d	O
using	O
liquid	O
and	O
gas	O
chromatography	I:C1720784
-	I:C1720784
mass	I:C1720784
spectrometry	I:C1720784
.	O

Exercise	O
-	O
induced	O
changes	O
in	O
intramuscular	O
metabolites	O
were	O
determine	O
d	O
using	O
liquid	O
and	O
gas	B:C1720784
chromatography	I:C1720784
-	I:C1720784
mass	I:C1720784
spectrometry	I:C1720784
.	O

Quadriceps	B:C0224440
fatigue	O
was	O
quantified	O
by	O
pre	O
-	O
to	O
post	O
-	O
exercise	O
changes	O
in	O
potentiated	O
quadriceps	O
twitch	O
torque	O
(	O
ΔQTsingle	O
)	O
evoked	O
by	O
electrical	O
femoral	O
nerve	I:C0015808
stimulation	O
.	O

Quadriceps	O
fatigue	B:C0015672
was	O
quantified	O
by	O
pre	O
-	O
to	O
post	O
-	O
exercise	O
changes	O
in	O
potentiated	O
quadriceps	O
twitch	O
torque	O
(	O
ΔQTsingle	O
)	O
evoked	O
by	O
electrical	O
femoral	O
nerve	I:C0015808
stimulation	O
.	O

Quadriceps	O
fatigue	O
was	O
quantified	O
by	O
pre	O
-	O
to	O
post	O
-	O
exercise	O
changes	O
in	O
potentiated	O
quadriceps	O
twitch	O
torque	O
(	O
ΔQTsingle	O
)	O
evoked	O
by	O
electrical	O
femoral	B:C0015808
nerve	I:C0015808
stimulation	O
.	O

Quadriceps	O
fatigue	O
was	O
quantified	O
by	O
pre	O
-	O
to	O
post	O
-	O
exercise	O
changes	O
in	O
potentiated	O
quadriceps	O
twitch	O
torque	O
(	O
ΔQTsingle	O
)	O
evoked	O
by	O
electrical	O
femoral	O
nerve	I:C0015808
stimulation	B:C1292856
.	O

Although	O
motoneuronal	B:C0026609
output	O
was	O
21	O
±	O
12	O
%	O
higher	O
during	O
FENT	O
compared	O
to	O
control	O
conditions	I:C2911690
(	O
P	O
<	O
0.05	O
)	O
,	O
time	O
to	O
complete	O
the	O
time	O
trial	O
was	O
similar	O
(	O
∼8.8	O
min	O
)	O
.	O

Although	O
motoneuronal	O
output	O
was	O
21	O
±	O
12	O
%	O
higher	O
during	O
FENT	B:C0678663
compared	O
to	O
control	O
conditions	I:C2911690
(	O
P	O
<	O
0.05	O
)	O
,	O
time	O
to	O
complete	O
the	O
time	O
trial	O
was	O
similar	O
(	O
∼8.8	O
min	O
)	O
.	O

Although	O
motoneuronal	O
output	O
was	O
21	O
±	O
12	O
%	O
higher	O
during	O
FENT	O
compared	O
to	O
control	B:C2911690
conditions	I:C2911690
(	O
P	O
<	O
0.05	O
)	O
,	O
time	O
to	O
complete	O
the	O
time	O
trial	O
was	O
similar	O
(	O
∼8.8	O
min	O
)	O
.	O

Although	O
motoneuronal	O
output	O
was	O
21	O
±	O
12	O
%	O
higher	O
during	O
FENT	O
compared	O
to	O
control	O
conditions	I:C2911690
(	O
P	O
<	O
0.05	O
)	O
,	O
time	O
to	O
complete	O
the	O
time	O
trial	B:C0008976
was	O
similar	O
(	O
∼8.8	O
min	O
)	O
.	O

Compared	O
to	O
control	B:C2911690
conditions	I:C2911690
,	O
power	O
output	O
during	O
FENT	O
was	O
10	O
±	O
4	O
%	O
higher	O
in	O
the	O
first	O
half	O
of	O
the	O
time	O
trial	O
,	O
but	O
11	O
±	O
5	O
%	O
lower	O
in	O
the	O
second	O
half	O
(	O
both	O
P	O
<	O
0.01	O
)	O
.	O

Compared	O
to	O
control	O
conditions	I:C2911690
,	O
power	O
output	O
during	O
FENT	B:C0678663
was	O
10	O
±	O
4	O
%	O
higher	O
in	O
the	O
first	O
half	O
of	O
the	O
time	O
trial	O
,	O
but	O
11	O
±	O
5	O
%	O
lower	O
in	O
the	O
second	O
half	O
(	O
both	O
P	O
<	O
0.01	O
)	O
.	O

Compared	O
to	O
control	O
conditions	I:C2911690
,	O
power	O
output	O
during	O
FENT	O
was	O
10	O
±	O
4	O
%	O
higher	O
in	O
the	O
first	O
half	O
of	O
the	O
time	O
trial	B:C0008976
,	O
but	O
11	O
±	O
5	O
%	O
lower	O
in	O
the	O
second	O
half	O
(	O
both	O
P	O
<	O
0.01	O
)	O
.	O

The	O
exercise	O
-	O
induced	O
increase	O
in	O
intramuscular	B:C0442117
inorganic	O
phosphate	I:C0031603
,	O
H	O
(+	I:C0033727
)	I:C0033727
,	O
adenosine	O
diphosphate	I:C0001459
,	O
lactate	O
and	O
phosphocreatine	O
depletion	O
was	O
55	O
±	O
30	O
,	O
62	O
±	O
18	O
,	O
129	O
±	O
63	O
,	O
47	O
±	O
14	O
(	O
P	O
<	O
0.001	O
)	O
and	O
27	O
±	O
14	O
%	O
(	O
P	O
<	O
0.01	O
)	O
greater	O
in	O
FENT	O
than	O
control	O
conditions	I:C2911690
.	O

The	O
exercise	O
-	O
induced	O
increase	O
in	O
intramuscular	O
inorganic	B:C0031603
phosphate	I:C0031603
,	O
H	O
(+	I:C0033727
)	I:C0033727
,	O
adenosine	O
diphosphate	I:C0001459
,	O
lactate	O
and	O
phosphocreatine	O
depletion	O
was	O
55	O
±	O
30	O
,	O
62	O
±	O
18	O
,	O
129	O
±	O
63	O
,	O
47	O
±	O
14	O
(	O
P	O
<	O
0.001	O
)	O
and	O
27	O
±	O
14	O
%	O
(	O
P	O
<	O
0.01	O
)	O
greater	O
in	O
FENT	O
than	O
control	O
conditions	I:C2911690
.	O

The	O
exercise	O
-	O
induced	O
increase	O
in	O
intramuscular	O
inorganic	O
phosphate	I:C0031603
,	O
H	B:C0033727
(+	I:C0033727
)	I:C0033727
,	O
adenosine	O
diphosphate	I:C0001459
,	O
lactate	O
and	O
phosphocreatine	O
depletion	O
was	O
55	O
±	O
30	O
,	O
62	O
±	O
18	O
,	O
129	O
±	O
63	O
,	O
47	O
±	O
14	O
(	O
P	O
<	O
0.001	O
)	O
and	O
27	O
±	O
14	O
%	O
(	O
P	O
<	O
0.01	O
)	O
greater	O
in	O
FENT	O
than	O
control	O
conditions	I:C2911690
.	O

The	O
exercise	O
-	O
induced	O
increase	O
in	O
intramuscular	O
inorganic	O
phosphate	I:C0031603
,	O
H	O
(+	I:C0033727
)	I:C0033727
,	O
adenosine	B:C0001459
diphosphate	I:C0001459
,	O
lactate	O
and	O
phosphocreatine	O
depletion	O
was	O
55	O
±	O
30	O
,	O
62	O
±	O
18	O
,	O
129	O
±	O
63	O
,	O
47	O
±	O
14	O
(	O
P	O
<	O
0.001	O
)	O
and	O
27	O
±	O
14	O
%	O
(	O
P	O
<	O
0.01	O
)	O
greater	O
in	O
FENT	O
than	O
control	O
conditions	I:C2911690
.	O

The	O
exercise	O
-	O
induced	O
increase	O
in	O
intramuscular	O
inorganic	O
phosphate	I:C0031603
,	O
H	O
(+	I:C0033727
)	I:C0033727
,	O
adenosine	O
diphosphate	I:C0001459
,	O
lactate	B:C0022924
and	O
phosphocreatine	O
depletion	O
was	O
55	O
±	O
30	O
,	O
62	O
±	O
18	O
,	O
129	O
±	O
63	O
,	O
47	O
±	O
14	O
(	O
P	O
<	O
0.001	O
)	O
and	O
27	O
±	O
14	O
%	O
(	O
P	O
<	O
0.01	O
)	O
greater	O
in	O
FENT	O
than	O
control	O
conditions	I:C2911690
.	O

The	O
exercise	O
-	O
induced	O
increase	O
in	O
intramuscular	O
inorganic	O
phosphate	I:C0031603
,	O
H	O
(+	I:C0033727
)	I:C0033727
,	O
adenosine	O
diphosphate	I:C0001459
,	O
lactate	O
and	O
phosphocreatine	B:C0031634
depletion	O
was	O
55	O
±	O
30	O
,	O
62	O
±	O
18	O
,	O
129	O
±	O
63	O
,	O
47	O
±	O
14	O
(	O
P	O
<	O
0.001	O
)	O
and	O
27	O
±	O
14	O
%	O
(	O
P	O
<	O
0.01	O
)	O
greater	O
in	O
FENT	O
than	O
control	O
conditions	I:C2911690
.	O

The	O
exercise	O
-	O
induced	O
increase	O
in	O
intramuscular	O
inorganic	O
phosphate	I:C0031603
,	O
H	O
(+	I:C0033727
)	I:C0033727
,	O
adenosine	O
diphosphate	I:C0001459
,	O
lactate	O
and	O
phosphocreatine	O
depletion	O
was	O
55	O
±	O
30	O
,	O
62	O
±	O
18	O
,	O
129	O
±	O
63	O
,	O
47	O
±	O
14	O
(	O
P	O
<	O
0.001	O
)	O
and	O
27	O
±	O
14	O
%	O
(	O
P	O
<	O
0.01	O
)	O
greater	O
in	O
FENT	B:C0678663
than	O
control	O
conditions	I:C2911690
.	O

The	O
exercise	O
-	O
induced	O
increase	O
in	O
intramuscular	O
inorganic	O
phosphate	I:C0031603
,	O
H	O
(+	I:C0033727
)	I:C0033727
,	O
adenosine	O
diphosphate	I:C0001459
,	O
lactate	O
and	O
phosphocreatine	O
depletion	O
was	O
55	O
±	O
30	O
,	O
62	O
±	O
18	O
,	O
129	O
±	O
63	O
,	O
47	O
±	O
14	O
(	O
P	O
<	O
0.001	O
)	O
and	O
27	O
±	O
14	O
%	O
(	O
P	O
<	O
0.01	O
)	O
greater	O
in	O
FENT	O
than	O
control	B:C2911690
conditions	I:C2911690
.	O

ΔQTsingle	O
was	O
greater	O
following	O
FENT	B:C0678663
than	O
control	O
conditions	I:C2911690
(	O
-	O
52	O
±	O
2	O
vs	O
-	O
31	O
±	O
1	O
%	O
,	O
P	O
<	O
0.001	O
)	O
and	O
this	O
difference	O
was	O
positively	O
correlated	O
with	O
the	O
difference	O
in	O
inorganic	O
phosphate	I:C0031603
(	O
r	O
(	O
2	O
)	O
=	O
0.79	O
;	O
P	O
<	O
0.01	O
)	O
and	O
H	O
(+	O
)	O
(	O
r	O
(	O
2	O
)	O
=	O
0.92	O
;	O
P	O
<	O
0.01	O
)	O
.	O

ΔQTsingle	O
was	O
greater	O
following	O
FENT	O
than	O
control	B:C2911690
conditions	I:C2911690
(	O
-	O
52	O
±	O
2	O
vs	O
-	O
31	O
±	O
1	O
%	O
,	O
P	O
<	O
0.001	O
)	O
and	O
this	O
difference	O
was	O
positively	O
correlated	O
with	O
the	O
difference	O
in	O
inorganic	O
phosphate	I:C0031603
(	O
r	O
(	O
2	O
)	O
=	O
0.79	O
;	O
P	O
<	O
0.01	O
)	O
and	O
H	O
(+	O
)	O
(	O
r	O
(	O
2	O
)	O
=	O
0.92	O
;	O
P	O
<	O
0.01	O
)	O
.	O

ΔQTsingle	O
was	O
greater	O
following	O
FENT	O
than	O
control	O
conditions	I:C2911690
(	O
-	O
52	O
±	O
2	O
vs	O
-	O
31	O
±	O
1	O
%	O
,	O
P	O
<	O
0.001	O
)	O
and	O
this	O
difference	O
was	O
positively	B:C1446409
correlated	O
with	O
the	O
difference	O
in	O
inorganic	O
phosphate	I:C0031603
(	O
r	O
(	O
2	O
)	O
=	O
0.79	O
;	O
P	O
<	O
0.01	O
)	O
and	O
H	O
(+	O
)	O
(	O
r	O
(	O
2	O
)	O
=	O
0.92	O
;	O
P	O
<	O
0.01	O
)	O
.	O

ΔQTsingle	O
was	O
greater	O
following	O
FENT	O
than	O
control	O
conditions	I:C2911690
(	O
-	O
52	O
±	O
2	O
vs	O
-	O
31	O
±	O
1	O
%	O
,	O
P	O
<	O
0.001	O
)	O
and	O
this	O
difference	O
was	O
positively	O
correlated	O
with	O
the	O
difference	O
in	O
inorganic	B:C0031603
phosphate	I:C0031603
(	O
r	O
(	O
2	O
)	O
=	O
0.79	O
;	O
P	O
<	O
0.01	O
)	O
and	O
H	O
(+	O
)	O
(	O
r	O
(	O
2	O
)	O
=	O
0.92	O
;	O
P	O
<	O
0.01	O
)	O
.	O

In	O
conclusion	O
,	O
during	O
whole	B:C0444584
body	I:C0444584
exercise	O
,	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
provide	O
feedback	O
to	O
the	O
CNS	O
which	O
,	O
in	O
turn	O
,	O
constrains	O
motoneuronal	O
output	O
to	O
the	O
active	O
skeletal	O
muscle	I:C0242692
.	O

In	O
conclusion	O
,	O
during	O
whole	O
body	I:C0444584
exercise	O
,	O
group	B:C0026845
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
provide	O
feedback	O
to	O
the	O
CNS	O
which	O
,	O
in	O
turn	O
,	O
constrains	O
motoneuronal	O
output	O
to	O
the	O
active	O
skeletal	O
muscle	I:C0242692
.	O

In	O
conclusion	O
,	O
during	O
whole	O
body	I:C0444584
exercise	O
,	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	B:C0027883
provide	O
feedback	O
to	O
the	O
CNS	O
which	O
,	O
in	O
turn	O
,	O
constrains	O
motoneuronal	O
output	O
to	O
the	O
active	O
skeletal	O
muscle	I:C0242692
.	O

In	O
conclusion	O
,	O
during	O
whole	O
body	I:C0444584
exercise	O
,	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
provide	O
feedback	B:C0678663
to	O
the	O
CNS	O
which	O
,	O
in	O
turn	O
,	O
constrains	O
motoneuronal	O
output	O
to	O
the	O
active	O
skeletal	O
muscle	I:C0242692
.	O

In	O
conclusion	O
,	O
during	O
whole	O
body	I:C0444584
exercise	O
,	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
provide	O
feedback	O
to	O
the	O
CNS	B:C3714787
which	O
,	O
in	O
turn	O
,	O
constrains	O
motoneuronal	O
output	O
to	O
the	O
active	O
skeletal	O
muscle	I:C0242692
.	O

In	O
conclusion	O
,	O
during	O
whole	O
body	I:C0444584
exercise	O
,	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
provide	O
feedback	O
to	O
the	O
CNS	O
which	O
,	O
in	O
turn	O
,	O
constrains	O
motoneuronal	B:C0026609
output	O
to	O
the	O
active	O
skeletal	O
muscle	I:C0242692
.	O

In	O
conclusion	O
,	O
during	O
whole	O
body	I:C0444584
exercise	O
,	O
group	O
III	I:C0026845
/	I:C0026845
IV	I:C0026845
muscle	I:C0026845
afferents	O
provide	O
feedback	O
to	O
the	O
CNS	O
which	O
,	O
in	O
turn	O
,	O
constrains	O
motoneuronal	O
output	O
to	O
the	O
active	O
skeletal	B:C0242692
muscle	I:C0242692
.	O

This	O
regulatory	B:C1327622
mechanism	O
limits	O
the	O
exercise	O
-	O
induced	O
intramuscular	O
metabolic	O
perturbation	O
,	O
preventing	O
an	O
abnormal	O
homeostatic	I:C4022950
challenge	O
and	O
excessive	O
peripheral	O
fatigue	O
.	O

This	O
regulatory	O
mechanism	O
limits	O
the	O
exercise	O
-	O
induced	O
intramuscular	B:C0442117
metabolic	O
perturbation	O
,	O
preventing	O
an	O
abnormal	O
homeostatic	I:C4022950
challenge	O
and	O
excessive	O
peripheral	O
fatigue	O
.	O

This	O
regulatory	O
mechanism	O
limits	O
the	O
exercise	O
-	O
induced	O
intramuscular	O
metabolic	O
perturbation	O
,	O
preventing	O
an	O
abnormal	B:C4022950
homeostatic	I:C4022950
challenge	O
and	O
excessive	O
peripheral	O
fatigue	O
.	O

This	O
regulatory	O
mechanism	O
limits	O
the	O
exercise	O
-	O
induced	O
intramuscular	O
metabolic	O
perturbation	O
,	O
preventing	O
an	O
abnormal	O
homeostatic	I:C4022950
challenge	B:C0805586
and	O
excessive	O
peripheral	O
fatigue	O
.	O

This	O
regulatory	O
mechanism	O
limits	O
the	O
exercise	O
-	O
induced	O
intramuscular	O
metabolic	O
perturbation	O
,	O
preventing	O
an	O
abnormal	O
homeostatic	I:C4022950
challenge	O
and	O
excessive	O
peripheral	B:C0205100
fatigue	O
.	O

This	O
regulatory	O
mechanism	O
limits	O
the	O
exercise	O
-	O
induced	O
intramuscular	O
metabolic	O
perturbation	O
,	O
preventing	O
an	O
abnormal	O
homeostatic	I:C4022950
challenge	O
and	O
excessive	O
peripheral	O
fatigue	B:C0015672
.	O

